← Back to Dashboard

Prezcobix

Protease inhibitor + CYP3A4 booster

Constituent drugs (2)

Darunavir

Loading structure...
3D not available

Cobicistat

Loading structure...
3D not available

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral protease
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (pmda.go.jp) PMDA approved Nov. 22, 2016fixed-dose combination of Darunavir, Cobicistat.